BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sciomer S, Moscucci F, Salvioni E, Marchese G, Bussotti M, Corrà U, Piepoli MF. Role of gender, age and BMI in prognosis of heart failure. Eur J Prev Cardiol 2020;27:46-51. [PMID: 33238736 DOI: 10.1177/2047487320961980] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Du Y, Yuan N, Yan J, Han G, Hu X, Zhang Y, Tian J. Identification of echocardiographic subgroups in patients with coronary heart disease combined with heart failure based on latent variable stratification. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.11.038] [Reference Citation Analysis]
2 Parenica J, Benesova K, Radvan M, Sanca O, Hlasensky J, Lokaj P, Ondrus T, Helanova K, Kala P, Dusek L, Jarkovsky J. COVID-19 vaccine booster significantly decreases the risk of intensive care unit hospitalization in heart failure patients during the Omicron variant wave: A population-based study. Front Cardiovasc Med 2022;9:998842. [DOI: 10.3389/fcvm.2022.998842] [Reference Citation Analysis]
3 Li Z, Rong H, Wu W, Huang T, Xu J, Li W. Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure. Emergency Medicine International 2022;2022:1-6. [DOI: 10.1155/2022/3689445] [Reference Citation Analysis]
4 Piccirillo G, Moscucci F, Corrao A, Carnovale M, Di Diego I, Lospinuso I, Caltabiano C, Mezzadri M, Rossi P, Magrì D. Noninvasive Hemodynamic Monitoring in Advanced Heart Failure Patients: New Approach for Target Treatments. Biomedicines 2022;10:2407. [DOI: 10.3390/biomedicines10102407] [Reference Citation Analysis]
5 Halasz G, Piepoli MF. Focus on population science. Eur J Prev Cardiol 2022;29:1369-71. [PMID: 35917441 DOI: 10.1093/eurjpc/zwac136] [Reference Citation Analysis]
6 Moscucci F, Lavalle F, Politi C, Campanale A, Baggio G, Sciomer S. Acute Coronary Syndrome in Women: a new and specific approach is needed. Eur J Prev Cardiol 2022:zwac143. [PMID: 35881512 DOI: 10.1093/eurjpc/zwac143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ebong IA, Defilippis EM, Hamad EA, Hsich EM, Randhawa VK, Billia F, Kassi M, Bhardwaj A, Byku M, Munagala MR, Rao RA, Hackmann AE, Gidea CG, Demarco T, Hall SA. Special Considerations in the Care of Women With Advanced Heart Failure. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.890108] [Reference Citation Analysis]
8 Huang YH, Cai WK, Yin SJ, Wang P, Li ZR, Yang Q, Zhou T, Meng R, Yang M, Guo Y, He GH. Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study. Eur J Prev Cardiol 2022:zwac122. [PMID: 35707983 DOI: 10.1093/eurjpc/zwac122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ou H, Zheng Y, Li M, Liang J, Chen H, Lang S, Li Q, Chen D, Lin Y, Chen Q, Sun Y, Zheng M, You T, Lin Q. The impacts of surgical mask in young healthy subjects on cardiopulmonary function and muscle performance: a randomized crossover trial. Arch Public Health 2022;80:138. [PMID: 35581631 DOI: 10.1186/s13690-022-00893-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen Z, Jiang H, He W, Li D, Lin M, Wang M, Shang M, Zhang W. The Association of Nutritional Risk Screening 2002 With 1-Year Re-hospitalization and the Length of Initial Hospital Stay in Patients With Heart Failure. Front Nutr 2022;9:849034. [DOI: 10.3389/fnut.2022.849034] [Reference Citation Analysis]
11 García R, Muñoz MA, Navas E, Vinyoles E, Verdú-Rotellar JM, Del Val JL. Variability in Cardiovascular Risk Factor Control in Patients with Heart Failure According to Gender and Socioeconomic Status. J Womens Health (Larchmt) 2022. [PMID: 35041531 DOI: 10.1089/jwh.2021.0404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yu Y, Jin C, Zhao C, Zhu S, Meng S, Ma H, Wang J, Xiang M. Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients. Front Cardiovasc Med 2021;8:761537. [PMID: 35004879 DOI: 10.3389/fcvm.2021.761537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Altukhays IA, Alosaimi SH, Alotaibi MA, Aamzami AA, Slais ZA, Al Zainaldeen AM, Hakami LH, Al Saber BF, Alessa AM, Alfardan ‎A, Alotaibi MA. Congestive Heart Failure: Diagnosis and Management in Primary Health Care. Arch Pharm Pract 2022;13:1-4. [DOI: 10.51847/kbs2ghpd1q] [Reference Citation Analysis]
14 Lin J, Zhou J, Xie G, Liu J. Efficacy and safety of sacubitril-valsartan in patients with heart failure: a systematic review and meta-analysis of randomized clinical trials: A PRISMA-compliant article. Medicine (Baltimore) 2021;100:e28231. [PMID: 34967357 DOI: 10.1097/MD.0000000000028231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Yáñez-Bisbe L, Garcia-Elias A, Tajes M, Almendros I, Rodríguez-Sinovas A, Inserte J, Ruiz-Meana M, Farré R, Farré N, Benito B. Aging Impairs Reverse Remodeling and Recovery of Ventricular Function after Isoproterenol-Induced Cardiomyopathy. Int J Mol Sci 2021;23:174. [PMID: 35008601 DOI: 10.3390/ijms23010174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Egocheaga I, Escobar C, Pallarés V, Obaya JC. [Dapagliflozin in the prevention and treatment of heart failure]. Semergen 2021;47 Suppl 1:11-7. [PMID: 34785155 DOI: 10.1016/j.semerg.2021.10.001] [Reference Citation Analysis]
17 McClung JA, Levy L, Garcia V, Stec DE, Peterson SJ, Abraham NG. Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications. Pharmacol Ther 2021;:107975. [PMID: 34499923 DOI: 10.1016/j.pharmthera.2021.107975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
18 Al Sharie S, Araydah M, Al-Azzam S, Karasneh R, Hammoudeh AJ. The participation of Arab women in randomised clinical trials for cardiovascular diseases. Int J Clin Pract 2021;:e14612. [PMID: 34235821 DOI: 10.1111/ijcp.14612] [Reference Citation Analysis]
19 Loosen SH, Roderburg C, Jahn JK, Joerdens M, Luedde T, Kostev K, Luedde M. Heart failure and depression: a comparative analysis with different types of cancer. Eur J Prev Cardiol 2021:zwab048. [PMID: 33984863 DOI: 10.1093/eurjpc/zwab048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Núñez J, Lorenzo M, Miñana G, Palau P, Monmeneu JV, López-Lereu MP, Gavara J, Marcos-Garcés V, Ríos-Navarro C, Pérez N, de Dios E, Núñez E, Sanchis J, Chorro FJ, Bayés-Genís A, Bodí V. Sex differences on new-onset heart failure in patients with known or suspected coronary artery disease. Eur J Prev Cardiol 2021:zwab078. [PMID: 33970216 DOI: 10.1093/eurjpc/zwab078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
21 Barradas-Pires A, Boyalla V, Dimopoulos K. Gender, an additional cardiovascular risk factor? Int J Cardiol 2021;331:270-2. [PMID: 33607191 DOI: 10.1016/j.ijcard.2021.02.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]